ATE475411T1 - Liposomenladung mit metallionen - Google Patents
Liposomenladung mit metallionenInfo
- Publication number
- ATE475411T1 ATE475411T1 AT02766998T AT02766998T ATE475411T1 AT E475411 T1 ATE475411 T1 AT E475411T1 AT 02766998 T AT02766998 T AT 02766998T AT 02766998 T AT02766998 T AT 02766998T AT E475411 T1 ATE475411 T1 AT E475411T1
- Authority
- AT
- Austria
- Prior art keywords
- metal ions
- liposome loading
- liposome
- loading
- liposomes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32667101P | 2001-10-03 | 2001-10-03 | |
US34152901P | 2001-12-17 | 2001-12-17 | |
US35675902P | 2002-02-15 | 2002-02-15 | |
US36207402P | 2002-03-07 | 2002-03-07 | |
US39427302P | 2002-07-09 | 2002-07-09 | |
PCT/CA2002/001501 WO2003028697A2 (en) | 2001-10-03 | 2002-10-03 | Liposome loading with metal ions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE475411T1 true ATE475411T1 (de) | 2010-08-15 |
Family
ID=27541066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02766998T ATE475411T1 (de) | 2001-10-03 | 2002-10-03 | Liposomenladung mit metallionen |
Country Status (11)
Country | Link |
---|---|
US (3) | US7238367B2 (de) |
EP (1) | EP1432403B1 (de) |
JP (2) | JP4822666B2 (de) |
AT (1) | ATE475411T1 (de) |
AU (1) | AU2002331481B2 (de) |
CA (1) | CA2462376C (de) |
DE (1) | DE60237162D1 (de) |
HK (1) | HK1066731A1 (de) |
IL (2) | IL161187A0 (de) |
TW (1) | TWI235066B (de) |
WO (1) | WO2003028697A2 (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100489701B1 (ko) * | 2002-10-09 | 2005-05-16 | 주식회사 태평양 | 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법 |
US8980310B2 (en) * | 2002-12-31 | 2015-03-17 | Bharat Serums and Vaccines, Ltd. | Non-pegylated long-circulating liposomes |
CA2520864A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Lipid particles having asymmetric lipid coating and method of preparing same |
CA2527130A1 (en) * | 2003-04-02 | 2004-10-14 | Paul Tardi | Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
CN1798544A (zh) * | 2003-04-02 | 2006-07-05 | 塞拉特药物股份有限公司 | 喜树碱和氟嘧啶的组合物 |
PT1744764E (pt) * | 2004-04-22 | 2012-08-30 | Celator Pharmaceuticals Inc | Formulações lipossómicas de agentes antraciclina e análogos de citidina |
US8658203B2 (en) * | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
CN103948545B (zh) | 2004-05-03 | 2017-10-03 | 益普生生物制药公司 | 用于药物输送的脂质体 |
CN1960729B (zh) | 2004-06-01 | 2012-04-11 | 泰尔茂株式会社 | 伊立替康制剂 |
EP3153159A1 (de) * | 2004-07-09 | 2017-04-12 | Robert Sabin | Zusammensetzungen mit einer kupferverbindung zur behandlung von erkrankungen bei säugetieren |
US7449196B2 (en) * | 2004-07-09 | 2008-11-11 | Robert Sabin | Anti tumor compositions and methods of use |
US8349360B2 (en) * | 2004-10-06 | 2013-01-08 | Bc Cancer Agency | Liposomes with improved drug retention for treatment of cancer |
JP4990786B2 (ja) * | 2004-11-05 | 2012-08-01 | イネックス ファーマシューティカルズ コーポレイション | 薬物リポソーム製剤を安定化するための組成物および方法 |
WO2006055903A1 (en) * | 2004-11-18 | 2006-05-26 | Celator Pharmaceuticals, Inc. | Method for loading multiple agents into delivery vehicles |
US8246983B2 (en) * | 2005-09-02 | 2012-08-21 | Northwestern University | Encapsulated arsenic drugs |
US20110020434A1 (en) * | 2005-09-02 | 2011-01-27 | O'halloran Thomas V | Nanoparticle arsenic-platinum compositions |
WO2007076117A2 (en) * | 2005-12-22 | 2007-07-05 | Celator Pharmaceuticals, Inc. | Liposomal formulations comprising secondary and tertiary amines and methods for preparing thereof |
EP3219307B1 (de) * | 2005-12-30 | 2021-09-08 | NuVessl Inc. | Nanolipidpartikel |
KR101333279B1 (ko) * | 2006-10-06 | 2013-11-27 | 에스씨아이엘 테크놀로지 게엠베하 | 약학적 응용을 위한 건조된 재구성 소포 형성 |
US20080213352A1 (en) * | 2007-03-02 | 2008-09-04 | Luna Innovations Incorporated | Liposome carriers for in vivo delivery of fullerenes |
WO2009097011A1 (en) | 2007-08-17 | 2009-08-06 | Celator Pharmaceuticals, Inc. | Improved platinum drug formulations |
KR101085824B1 (ko) * | 2009-03-11 | 2011-11-23 | 한국유나이티드제약 주식회사 | 생체적합성 고분자를 이용한 다기능성 조영제 및 이의 제조방법 |
US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
US10688026B2 (en) | 2009-04-27 | 2020-06-23 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
DK177532B1 (en) * | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
JP2012236772A (ja) * | 2009-09-28 | 2012-12-06 | Terumo Corp | スピカマイシン誘導体を有するリポソーム製剤 |
US9844656B2 (en) * | 2010-03-01 | 2017-12-19 | The Regents Of The University Of California | Localization of agents at a target site with a composition and an energy source |
WO2011119995A2 (en) | 2010-03-26 | 2011-09-29 | Cerulean Pharma Inc. | Formulations and methods of use |
PL226015B1 (pl) * | 2011-03-03 | 2017-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna |
KR101371698B1 (ko) * | 2011-06-30 | 2014-03-07 | 한국화학연구원 | 진단 및 치료를 위한 이중기능성 리포솜 및 그의 제조방법 |
KR102284689B1 (ko) | 2011-10-21 | 2021-08-02 | 셀라토 파마슈티칼즈, 인코포레이티드 | 동결건조된 리포좀 |
US20140378404A1 (en) * | 2011-10-25 | 2014-12-25 | Nektar Therapeutics | Treatment of Patients Suffering from Cancer |
JP2015524411A (ja) | 2012-07-18 | 2015-08-24 | オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. | エポキシケトン系プロテアソーム阻害剤のリポソーム組成物 |
ES2442450B1 (es) * | 2012-08-09 | 2014-12-12 | Enoc Solutions, S.L. | Liposomas vacíos como adyuvante de diferentes principios activos, administrados independientemente y en su forma galénica convencional |
MX2015005992A (es) | 2012-11-20 | 2016-03-07 | Spectrum Pharmaceuticals Inc | Metodo mejorado para la preparacion de la vincristina liposomal encapsulada para el uso terapeutico. |
US9993427B2 (en) * | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
US10758458B2 (en) | 2014-09-25 | 2020-09-01 | Premier Dental Products Company | Bondable microcapsules and surface functionalized fillers |
US10864168B2 (en) | 2014-10-29 | 2020-12-15 | The Regents Of The University Of California | Bioactive delivery vehicles |
TWI678213B (zh) | 2015-07-22 | 2019-12-01 | 美商史倍壯製藥公司 | 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物 |
EP3362049A1 (de) | 2015-10-16 | 2018-08-22 | Ipsen Biopharm Ltd. | Stabilisierung von pharmazeutischen camptothecinzusammensetzungen |
JP6697541B2 (ja) * | 2016-01-07 | 2020-05-20 | ウエスタン ユニバーシティ オブ ヘルス サイエンシーズ | 膀胱癌処置のための処方物 |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
CN113473980A (zh) | 2019-03-01 | 2021-10-01 | 弗拉梅尔爱尔兰有限公司 | 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物 |
CA3183397A1 (en) | 2020-06-18 | 2021-12-23 | Daryl C. Drummond | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof |
US20220041595A1 (en) | 2020-07-28 | 2022-02-10 | Jazz Pharmaceuticals Ireland Limited | Chiral synthesis of fused bicyclic raf inhibitors |
KR20230058399A (ko) | 2020-07-28 | 2023-05-03 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 융합된 바이사이클릭 raf 억제제 및 이의 사용 방법 |
US11980636B2 (en) | 2020-11-18 | 2024-05-14 | Jazz Pharmaceuticals Ireland Limited | Treatment of hematological disorders |
AU2021385572A1 (en) | 2020-11-25 | 2023-06-22 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids, and related methods of use |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932657A (en) * | 1973-11-12 | 1976-01-13 | The United States Of America As Represented By The United States Energy Research And Development Administration | Liposome encapsulation of chelating agents |
JPS5933287A (ja) * | 1982-08-19 | 1984-02-23 | Hidetoshi Tsuchida | 対面型ポルフイリン金属錯体を包接したリン脂質リポソ−ムおよび酸素吸脱着剤 |
JPS6176414A (ja) * | 1984-09-21 | 1986-04-18 | Shionogi & Co Ltd | リポソーム製剤の製法 |
JPH0639382B2 (ja) * | 1985-03-29 | 1994-05-25 | 財団法人生産開発科学研究所 | リン脂質リポソ−ム |
US4797285A (en) * | 1985-12-06 | 1989-01-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Lipsome/anthraquinone drug composition and method |
US4898735A (en) * | 1985-12-06 | 1990-02-06 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Liposome/doxorubicin composition and method |
JPH0751496B2 (ja) * | 1986-04-02 | 1995-06-05 | 武田薬品工業株式会社 | リポソ−ムの製造法 |
MX9203808A (es) | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
ES2067755T3 (es) * | 1989-06-22 | 1995-04-01 | Vestar Inc | Proceso de encapsulado. |
US5227170A (en) * | 1989-06-22 | 1993-07-13 | Vestar, Inc. | Encapsulation process |
US5010073A (en) * | 1989-10-05 | 1991-04-23 | The Rockefeller University | Use of liposomes as carriers for metalloporphyrins |
US5270053A (en) * | 1990-04-03 | 1993-12-14 | Ciba-Geigy Corp. | Parenterally administerable liposome formulation comprising synthetic lipid |
DE4134158C2 (de) * | 1991-10-11 | 1997-02-13 | Max Delbrueck Centrum | Verwendung von Carboplatin in lyotrophen Mesophasen zur Überwindung einer durch Zytostatika ausgelösten Leukopenie |
CA2137145A1 (en) * | 1992-06-08 | 1993-12-23 | Mark S. Chagnon | Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
US6764693B1 (en) * | 1992-12-11 | 2004-07-20 | Amaox, Ltd. | Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
US6274116B1 (en) * | 1993-06-03 | 2001-08-14 | Reagents Of The University Of California | Compositions for boron delivery to mammalian tissue |
CA2126648C (en) * | 1993-11-09 | 2000-10-10 | Tomas De Paoli | Liposomes containing bioavailable iron (ii) and method for obtaining them |
DE4341479A1 (de) * | 1993-12-02 | 1995-06-08 | Deutsches Rheuma Forschungszen | Verwendung von Metallothioneinen oder deren Apothioneinen zur Herstellung von Arzneimitteln mit antiviraler Wirkung |
US5466467A (en) * | 1994-03-30 | 1995-11-14 | The United States Of America As Represented By The Secretary Of The Navy | Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes |
GB9420390D0 (en) | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
GB9500116D0 (en) * | 1995-01-05 | 1995-03-01 | Ciba Geigy Ag | Pharmaceutical compositions |
US5837282A (en) * | 1996-10-30 | 1998-11-17 | University Of British Columbia | Ionophore-mediated liposome loading |
US5843475A (en) * | 1996-12-06 | 1998-12-01 | Board Of Regents, The University Of Texas System | Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes |
JP2002515417A (ja) | 1998-05-19 | 2002-05-28 | エスディジー、インコーポレイテッド | 標的指向リポソーム薬剤送達システム |
WO2001085131A2 (en) | 2000-05-11 | 2001-11-15 | Celator Technologies Inc. | Lipid carrier compositions for improved drug retention |
AU2001282855A1 (en) * | 2000-05-23 | 2001-12-03 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Immobilized metalchelate complexes for catalysis and decontamination of pesticides and chemical warfare nerve-agents |
US6416745B1 (en) * | 2001-05-03 | 2002-07-09 | Block Drug Company, Inc. | Dental composition for treating hypersensitive teeth |
-
2002
- 2002-10-03 US US10/264,818 patent/US7238367B2/en not_active Expired - Lifetime
- 2002-10-03 DE DE60237162T patent/DE60237162D1/de not_active Expired - Lifetime
- 2002-10-03 IL IL16118702A patent/IL161187A0/xx unknown
- 2002-10-03 AT AT02766998T patent/ATE475411T1/de not_active IP Right Cessation
- 2002-10-03 AU AU2002331481A patent/AU2002331481B2/en not_active Expired
- 2002-10-03 EP EP02766998A patent/EP1432403B1/de not_active Expired - Lifetime
- 2002-10-03 JP JP2003532030A patent/JP4822666B2/ja not_active Expired - Lifetime
- 2002-10-03 CA CA2462376A patent/CA2462376C/en not_active Expired - Lifetime
- 2002-10-03 WO PCT/CA2002/001501 patent/WO2003028697A2/en active Application Filing
- 2002-10-03 TW TW091122851A patent/TWI235066B/zh not_active IP Right Cessation
-
2004
- 2004-03-31 IL IL161187A patent/IL161187A/en active IP Right Grant
- 2004-12-10 HK HK04109790.9A patent/HK1066731A1/xx not_active IP Right Cessation
-
2005
- 2005-10-21 US US11/256,445 patent/US20060193904A1/en not_active Abandoned
-
2007
- 2007-08-20 US US11/842,130 patent/US7744921B2/en not_active Expired - Lifetime
-
2011
- 2011-04-01 JP JP2011081637A patent/JP2011157376A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL161187A0 (en) | 2004-08-31 |
EP1432403A2 (de) | 2004-06-30 |
EP1432403B1 (de) | 2010-07-28 |
DE60237162D1 (de) | 2010-09-09 |
WO2003028697A2 (en) | 2003-04-10 |
US20030091621A1 (en) | 2003-05-15 |
AU2002331481B2 (en) | 2008-04-24 |
US7238367B2 (en) | 2007-07-03 |
US20060193904A1 (en) | 2006-08-31 |
JP2005508921A (ja) | 2005-04-07 |
CA2462376A1 (en) | 2003-04-10 |
US7744921B2 (en) | 2010-06-29 |
TWI235066B (en) | 2005-07-01 |
CA2462376C (en) | 2010-12-14 |
US20080044464A1 (en) | 2008-02-21 |
HK1066731A1 (en) | 2005-04-01 |
IL161187A (en) | 2012-10-31 |
JP4822666B2 (ja) | 2011-11-24 |
WO2003028697A3 (en) | 2003-05-30 |
JP2011157376A (ja) | 2011-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE475411T1 (de) | Liposomenladung mit metallionen | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
DE60308885D1 (de) | Herstellung von metallkomplexen | |
MY130718A (en) | Antitumor compounds and methods | |
HK1071640A1 (en) | Housing made of fire-inhibiting material | |
BR0111541A (pt) | Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina | |
SE0300826L (sv) | Leverans av emulsionssprängämnen | |
HUP0303649A3 (en) | Liposome targeting of matrix metalloproteinase inhibitors | |
AR038533A1 (es) | Desbridador de heridas enzimatico de termolisina | |
TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
AU2001283586A1 (en) | Enhancement of the action of anti-infective agents | |
DE60025494D1 (de) | Epothilon zusammensetzungen | |
MXPA03009014A (es) | Suministro mejorado de agentes beneficos. | |
DE50213942D1 (de) | Eschichten von metallischen bauteilen | |
ITRM20010445A0 (it) | Alfa-chetoglutarati di principi attivi e composizioni che li contengono. | |
PT1303520E (pt) | Compostos terapêuticos e métodos | |
AU2002352815A8 (en) | Use of paecilomyces spp. as pathogenic agents against subterranean termites | |
ATE345778T1 (de) | (ester)-lysolecithine in liposomen | |
DE50207379D1 (de) | Nachweis von entzündungen | |
MY137953A (en) | New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent | |
AU2002350344A1 (en) | Individualization of therapy with antihistamines | |
JP2004232179A5 (de) | ||
FI20001483A0 (fi) | Sijaintiriippuvaisten palvelujen toimittaminen | |
CA96910S (en) | Flag | |
ITTO20000068V0 (it) | Plantaroller massaggiatore, distensore e stimolatore dell'arco plantare. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |